Bott competitive analysis

Explore patent oppositions filed by Bott against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIMApr 9, 2026
Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHAMar 17, 2026
Food Compositions For Weight ManagementNESTLEMar 10, 2026
Insulin Control In Overweight Or Obese Adult During Life Time InterventionNUTRICIAJan 19, 2026
Treatment Of Breast Cancer Using Combination Therapies Comprising Gdc-9545 And Gdc-0077GENENTECHDec 29, 2025
Polymorphs And Solid Forms Of (S)-2-((2-((S)-4-(Difluoromethyl)-2-Oxooxazolidin-3-Yl)-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepin-9-Yl)Amino)Propanamide, And Methods Of ProductionF HOFFMANN LA ROCHEDec 19, 2025
Powders Containing A Buffer Salt And An Amino Acid, Reconstitution Of Such A Powder Into A Nutritional Product, And Methods Of Using Such A Nutritional ProductNESTLENov 14, 2025
Infant Formula For Feeding Infants Receiving Infant Formula And Human Breast MilkNUTRICIANov 11, 2025
Combination DrugCHUGAI SEIYAKU KABUSHIKI KAISHASep 24, 2025
Nutritional CompositionNUTRICIASep 22, 2025

Latest PTAB cases involving Bott

Discover the latest PTAB cases involving Bott, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bott with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ABBOTT LABORATORIES2448131
NESTEC46208 - -
NESTLE194271 - -
NUTRICIA170215 - -